Skip to search formSkip to main content

EDL-155

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
PURPOSE OF REVIEW Mitochondrial disease is a heterogeneous group of energy metabolism disorders that present across all ages with… Expand
  • table 1
  • table 2
Is this relevant?
2010
2010
PURPOSE. To investigate the effectiveness of a novel isoquinoline derivative, EDL-155, in killing retinoblastoma in vitro and in… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 7
Is this relevant?
2009
2009
Our group has used the tetrahydroisoquinoline derivative EDL-155 to treat glioblastoma in animal models and it is currently being… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2008
2008
The effects of 1-(biphenyl-4-ylmethyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol (EDL-155) on the growth of glioma was tested in… Expand
Is this relevant?
2007
2007
PurposeTetrahydroisoquinolines (THIs) have demonstrated anti-cancer activity in rodent models of glioma, a form of brain cancer… Expand
  • table 1
  • figure 1
  • figure 2
Is this relevant?